Antimicrobial activity of novel synthetic peptides derived from indolicidin and ranalexin against Streptococcus pneumoniae

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Jindal, Hassan Mahmood ^a   Le, Cheng Foh ^b   Yusof, Mohd Yasim Mohd ^a   Velayuthan, Rukumani Devi ^a   Lee, Vannajan Sanghiran ^a   Zain, Sharifuddin Md ^a   Isa, Diyana Mohd ^a   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFTRIAXONE; ERYTHROMYCIN; INDOLICIDIN DERIVATIVE; INDOLICIDIN DERIVATIVE PLUS RANALEXIN DERIVATIVE; PNEUMOLYSIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN PSPA; RANALEXIN DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CYCLOPEPTIDE; INDOLICIDIN; PEPTIDE; RANALEXIN;

ARTICLE; BACTERICIDAL ACTIVITY; BINDING AFFINITY; COMPUTER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG POTENCY; DRUG PROTEIN BINDING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; AMINO ACID SEQUENCE; BINDING SITE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; STAPHYLOCOCCUS AUREUS; SYNTHESIS; TUMOR CELL LINE;

STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; CELL LINE, TUMOR; CELL SURVIVAL; ESCHERICHIA COLI; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PEPTIDES, CYCLIC; PROTEIN STRUCTURE, TERTIARY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84935019262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128532     Document Type: Article

References (66)

1. Aljunid S, Abuduxike G, Ahmed Z, Sulong S, Nur AM, Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infect Dis [Internet]. BioMed Central Ltd; 2011 Jan [cited 2014 Jun 26]; 11(1):248. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3189895&tool = pmcentrez&rendertype = abstract
2. Chaïbou Y, Sanou I, Congo-Ouedraogo M, Kienou MC, Ouattara K, Somlaré H, et al. Streptococcus pneumoniae invasive infections in Burkina Faso, 2007 to 2011. Médecine Mal Infect [Internet]. Elsevier Masson SAS; 2014 Mar [cited 2014 May 13]; 44(3):117-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24612507
3. Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine [Internet]. 2007 Jun 28 [cited 2014 May 18]; 25(27):4996-5005. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17524530 PMID: 17524530
4. AlonsoDeVelasco E, Verheul AF, Verhoef J, Snippe H. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev [Internet]. 1995 Dec; 59(4):591-603. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=239389&tool = pmcentrez&rendertype = abstract PMID: 8531887
5. Moschioni M, De Angelis G, Harfouche C, Bizzarri E, Filippini S, Mori E, et al. Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations. Vaccine [Internet]. Elsevier Ltd; 2012 Feb 8 [cited 2014 May 18]; 30(7):1349-56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22210141 doi: 10.1016/j.vaccine.2011.12.080 PMID: 22210141
6. Mitchell a M, Mitchell TJ. Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect [Internet]. 2010 May; 16(5):411-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20132250 doi: 10.1111/j.1469-0691.2010.03183.x PMID: 20132250
7. Hirst R a, Kadioglu a, O'callaghan C, Andrew PW. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol [Internet]. 2004 Nov [cited 2014 Apr 29]; 138(2):195-201. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1809205&tool = pmcentrez&rendertype = abstract PMID: 15498026
8. Staples M, Jennison A V, Ariotti L, Hicks V, Graham RM a, Smith H V. Prevalence and molecular characterisation of Streptococcus pneumoniae serotype 6C in Queensland, Australia. Diagn Microbiol Infect Dis [Internet]. Elsevier B.V.; 2014 Mar [cited 2014 May 13]; 78(3):307-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24369995 doi: 10.1016/j.diagmicrobio.2013.11.017 PMID: 24369995
9. Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine [Internet]. 2012 May 21 [cited 2014 May 18]; 30(24):3503-14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22475858 doi: 10.1016/j.vaccine.2012.03.066 PMID: 22475858
10. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet [Internet]. Elsevier Ltd; 2009 Sep 12 [cited 2014 May 18]; 374(9693):893-902. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19748398 doi: 10.1016/S0140-6736(09)61204-6 PMID: 19748398
11. Lin T-Y, Shah NK, Brooks D, Garcia CS. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine [Internet]. Elsevier Ltd; 2010 Nov 10 [cited 2014 May 18]; 28(48):7589-605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20674872 doi: 10.1016/j.vaccine.2010.07.053 PMID: 20674872
12. Bravo LC. Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine [Internet]. 2009 Dec 9 [cited 2014 May 18]; 27(52):7282-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19393708 doi: 10.1016/j.vaccine.2009.04.046 PMID: 19393708
13. Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev [Internet]. 2001 [cited 2014 Jun 2]; 65(2):187-207; first page, table of contents. Available from: http://mmbr.asm.org/content/65/2/187.short PMID: 11381099
14. Fassi Fehri L, Wróblewski H, Blanchard A. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob Agents Chemother [Internet]. 2007 Feb [cited 2014 Jun 2]; 51(2):468-74. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1797740&tool = pmcentrez&rendertype = abstract PMID: 17101680
15. Li L, Shi Y, Cheserek MJ, Su G, Le G. Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes. Appl Microbiol Biotechnol [Internet]. 2013 Feb [cited 2013 Aug 15]; 97(4):1711-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22923068 doi: 10.1007/s00253-012-4352-1 PMID: 22923068
16. Sánchez-Vásquez L, Silva-Sanchez J, Jiménez-Vargas JM, Rodríguez-Romero A, Muñoz-Garay C, Rodríguez MC, et al. Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. Biochim Biophys Acta [Internet]. Elsevier B.V.; 2013 Jun [cited 2013 Aug 15]; 1830(6):3427-36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23403131 doi: 10.1016/j.bbagen.2013.01.028 PMID: 23403131
17. Wang K, Yan J, Dang W, Liu X, Chen R, Zhang J, et al. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of Polybia paulista. Peptides [Internet]. Elsevier Inc.; 2013 Jan [cited 2014 Jun 2]; 39:80-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23159560 doi: 10.1016/j.peptides.2012.11.002 PMID: 23159560
18. Urbán E, Nagy E, Pál T, Sonnevend A, Conlon JM. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Int J Antimicrob Agents [Internet]. 2007 Mar [cited 2013 Aug 15]; 29(3):317-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17196372 PMID: 17196372
19. Serrano GN, Zhanel GG, Schweizer F. Antibacterial activity of ultrashort cationic lipo-beta-peptides. Antimicrob Agents Chemother [Internet]. 2009 May [cited 2013 Aug 15]; 53(5):2215-7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2681537&tool = pmcentrez&rendertype = abstract doi: 10.1128/AAC.01100-08 PMID: 19237652
20. Badosa E, Ferre R, Planas M, Feliu L, Besalú E, Cabrefiga J, et al. A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Peptides [Internet]. 2007 Dec [cited 2013 Aug 15]; 28(12):2276-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17980935 PMID: 17980935
21. Hara S, Mukae H, Sakamoto N, Ishimoto H, Amenomori M, Fujita H, et al. Plectasin has antibacterial activity and no affect on cell viability or IL-8 production. Biochem Biophys Res Commun [Internet]. 2008 Oct 3 [cited 2013 Aug 15]; 374(4):709-13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18675251 doi: 10.1016/j.bbrc.2008.07.093 PMID: 18675251
22. Torcato IM, Huang Y-H, Franquelim HG, Gaspar D, Craik DJ, Castanho M a RB, et al. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. Biochim Biophys Acta [Internet]. Elsevier B.V.; 2013 Mar [cited 2013 Aug 15]; 1828(3):944-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23246973 doi: 10.1016/j.bbamem.2012.12.002 PMID: 23246973
23. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev [Internet]. 2006 Jul [cited 2013 Aug 7]; 19(3):491-511. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1539102&tool = pmcentrez&rendertype = abstract PMID: 16847082
24. Clark DP, Durell S, Maloy WL, Zaslof M. Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the baterial antibiotic, Polymyxin. J Biol Chem [Internet]. 1994; 269(14):10849-55. Available from: http://www.jbc.org/content/269/14/10849.long PMID: 8144672
25. Selsted ME, Novotnytll MJ, Morris WL, Tang Y, Smith W, Cullor JS. Indolicidin, a Novel Bactericidal Tridecapeptide Amide from Neutrophils. J Biol Chem [Internet]. 1991; 267(7):4292-5. Available from: http://www.jbc.org/content/267/7/4292.long
26. Duval E, Zatylny C, Laurencin M, Baudy-Floc'h M, Henry J. KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity. Peptides [Internet]. 2009 Sep [cited 2014 Jun 2]; 30(9):1608-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19573572 doi: 10.1016/j.peptides.2009.06.022 PMID: 19573572
27. Chan D, Prenner E, Vogel H. Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta (BBA)- ...[Internet]. 2006 [cited 2014 Jul 9]; 1758:1184-202. Available from: http://www.sciencedirect.com/science/article/pii/S0005273606001404 PMID: 16756942
28. Clark D, Durell S, Maloy W, Zasloff M. Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J Biol Chem [Internet]. 1994 [cited 2014 Sep 24]; 269(14):10849-55. Available from: http://www.jbc.org/content/269/14/10849.short PMID: 8144672
29. Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 2009 Jan; 37(Database issue):D933-7. doi: 10.1093/nar/gkn823 PMID: 18957441
30. Wilkins MR, Gasteiger E, Bairoch a, Sanchez JC, Williams KL, Appel RD, et al. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999 Jan; 112:531-52. PMID: 10027275
31. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard - Ninth Edition. Ninth Edit. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2012.
32. Xi D, Teng D, Wang X, Mao R, Yang Y, Xiang W, et al. Design, expression and characterization of the hybrid antimicrobial peptide LHP7, connected by a flexible linker, against Staphylococcus and Streptococcus. Process Biochem [Internet]. 2013 Mar [cited 2013 Aug 15]; 48(3):453-61. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1359511313000317 doi: 10.1016/j.ejps.2012.12.003 PMID: 23238172
33. Giacometti a, Cirioni O, Barchiesi F, Fortuna M, Scalise G. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J Antimicrob Chemother [Internet]. 1999 Nov; 44(5):641-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10552980 PMID: 10552980
34. Kiefer F, Arnold K, Künzli M, Bordoli L, Schwede T. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res [Internet]. 2009 Jan [cited 2014 Jul 11]; 37(Database issue):D387-92. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2686475&tool = pmcentrez&rendertype = abstract doi: 10.1093/nar/gkn750 PMID: 18931379
35. Kopp J, Schwede T. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res [Internet]. 2004 Jan 1 [cited 2014 Oct 9]; 32(Database issue): D230-4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=308743&tool = pmcentrez&rendertype = abstract PMID: 14681401
36. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res [Internet]. 2003 Jul 1 [cited 2014 Oct 28]; 31(13):3381-5. Available from: http://nar.oxfordjournals.org/lookup/doi/10.1093/nar/gkg520 PMID: 12824332
37. Momany FA, Rone R. Validation of the general purpose QUANTA 3.2/CHARMm force field. J Comput Chem [Internet]. 1992 Sep [cited 2014 Oct 10]; 13(7):888-900. Available from: http://doi.wiley.com/10.1002/jcc.540130714
38. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr [Internet]. 1993 Apr 1 [cited 2014 Jul 13]; 26(2):283-91. Available from: http://scripts.iucr.org/cgi-bin/paper?S0021889892009944
39. Sippl MJ. Boltzmann's principle, knowledge-based mean fields and protein folding. An approach to the computational determination of protein structures. J Comput Aided Mol Des [Internet]. 1993 Aug [cited 2014 Oct 10]; 7(4):473-501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8229096 PMID: 8229096
40. Lüthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature [Internet]. 1992; 356(6364):83-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1538787 PMID: 1538787
41. Discovery Studio, version 2.5.5; Accelrys Inc.: San Diego, CA, USA, 2009.
42. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of comparative protein modeling by MODELLER. Proteins [Internet]. 1995 Nov [cited 2014 Oct 10]; 23(3):318-26. Available from: http://onlinelibrary.wiley.com/doi/10.1002/prot.340230306/pdf PMID: 8710825
43. Kaur H, Garg A, Raghava GPS. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett. 2007; 14(7):626-31. PMID: 17897087
44. Trott O, Olson AJ. Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31(2):455-61. doi: 10.1002/jcc.21334 PMID: 19499576
45. Jabés D, Brunati C, Candiani G, Riva S, Romanó G, Donadio S. Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens. Antimicrob Agents Chemother [Internet]. 2011 Apr [cited 2013 Aug 15]; 55(4):1671-6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3067139&tool = pmcentrez&rendertype = abstract doi: 10.1128/AAC.01288-10 PMID: 21220527
46. Lin M-C, Hui C-F, Chen J-Y, Wu J-L. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus. Peptides [Internet]. Elsevier Inc.; 2013 Jun [cited 2014 May 25]; 44:139-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23598079 doi: 10.1016/j.peptides.2013.04.004 PMID: 23598079
47. Nüsslein K, Arnt L, Rennie J, Owens C, Tew GN. Broad-spectrum antibacterial activity by a novel abiogenic peptide mimic. Microbiology [Internet]. 2006 Jul [cited 2014 Jun 2]; 152(Pt 7):1913-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16804167
48. Tian Z, Dong T, Teng D, Yang Y, Wang J. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol [Internet]. 2009 Apr [cited 2014 Jul 10]; 82(6):1097-103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19148638 doi: 10.1007/s00253-008-1839-x PMID: 19148638
49. Yeaman MMR, Yount NNY. Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol Rev [Internet]. 2003 [cited 2013 Sep 6]; 55(1):27-55. Available from: http://pharmrev.aspetjournals.org/content/55/1/27.short PMID: 12615953
50. Lohner K, Latal a, Lehrer RI, Ganz T. Differential scanning microcalorimetry indicates that human defensin, HNP-2, interacts specifically with biomembrane mimetic systems. Biochemistry [Internet]. 1997 Feb 11; 36(6):1525-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9063901 PMID: 9063901
51. Tachi T, Epand RF, Epand RM, Matsuzaki K. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. Biochemistry [Internet]. 2002 Aug 27; 41(34):10723-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12186559 PMID: 12186559
52. Vaara M. New approaches in peptide antibiotics. Curr Opin Pharmacol [Internet]. 2009 Oct [cited 2013 Aug 15]; 9(5):571-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19734091 doi: 10.1016/j.coph.2009.08.002 PMID: 19734091
53. Falla TJ, Hancock REW. Improved activity of a synthetic indolicidin analog. Antimicrob Agents Chemother. 1997; 41(4):771-5. PMID: 9087487
54. Yang ST, Shin SY, Hahm KS, Kim JI. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int J Antimicrob Agents. 2006; 27(4):325-30. PMID: 16563706
55. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother [Internet]. 2007 Apr [cited 2013 Aug 15]; 51(4):1398-406. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1855469&tool = pmcentrez&rendertype = abstract PMID: 17158938
56. Brogden NK, Brogden K a. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents [Internet]. Elsevier B.V.; 2011 Sep [cited 2014 Jun 2]; 38(3):217-25. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3159164&tool = pmcentrez&rendertype = abstract doi: 10.1016/j.ijantimicag.2011.05.004 PMID: 21733662
57. Saugar JM, Rodríguez-Hernández MJ, de la Torre BG, Pachón-Ibañez ME, Fernández-Reyes M, Andreu D, et al. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action. Antimicrob Agents Chemother [Internet]. 2006 Apr [cited 2014 Aug 11]; 50(4):1251-6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1426946&tool = pmcentrez&rendertype = abstract PMID: 16569836
58. Beisswenger C, Bals R. Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci [Internet]. 2005 Jun; 6(3):255-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15974951 PMID: 15974951
59. Sun H, Greathouse D V, Andersen OS, Koeppe RE. The preference of tryptophan for membrane interfaces: insights from N-methylation of tryptophans in gramicidin channels. J Biol Chem [Internet]. 2008 Aug 8 [cited 2013 Aug 20]; 283(32):22233-43. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2494914&tool = pmcentrez&rendertype = abstract doi: 10.1074/jbc.M802074200 PMID: 18550546
60. Liu Z, Brady A, Young A, Rasimick B, Chen K, Zhou C, et al. Length effects in antimicrobial peptides of the (RW)n series. Antimicrob Agents Chemother. 2007; 51(2):597-603. PMID: 17145799
61. Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, et al. De novo generation of cationic antimicrobial peptides: Influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother. 2005; 49(1):316-22. PMID: 15616311
62. Zhu WL, Lan H, Park Y, Yang S-T, Kim J Il, Park I-S, et al. Effects of Pro - > peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide. Biochemistry [Internet]. 2006 Oct 31; 45(43):13007-17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17059217 PMID: 17059217
63. Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, et al. Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity. J Biol Chem [Internet]. 2012 Jan 2 [cited 2014 Jul 13]; 287(1):233-44. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3249074&tool = pmcentrez&rendertype = abstract doi: 10.1074/jbc.M111.279281 PMID: 22057278
64. Matsuzaki K. Control of cell selectivity of antimicrobial peptides [Internet]. Biochimica et Biophysica Acta - Biomembranes. Elsevier B.V.; 2009. p. 1687-92. Available from: http://dx.doi.org/10.1016/j.bbamem.2008.09.013
65. Hirst R a, Gosai B, Rutman A, Guerin CJ, Nicotera P, Andrew PW, et al. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. J Infect Dis [Internet]. 2008 Mar 1 [cited 2014 May 13]; 197(5):744-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18260758 doi: 10.1086/527322 PMID: 18260758
66. Ren B, Li J, Genschmer K, Hollingshead SK, Briles DE. The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro. Clin Vaccine Immunol [Internet]. 2012 Oct [cited 2014 May 7]; 19(10):1574-82. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3485889&tool = pmcentrez&rendertype = abstract PMID: 22855389